Compare Ocular Redness

0 Products

reset all

At-a-Glance

Description

FDA

CE Mark

Active Ingredients

Application

Status

Strength

remove

Lumify

Bausch + Lomb Inc.

Mechanism of Action: Brimonidine is an α-2 adrenergic receptor agonist that primarily constricts the venules which reduces redness while maintaining oxygen availability to surrounding tissues.
Dosage: One drop in the affected eye(s) every 6-8 hours, not to exceed more than 4 times daily.

Lumify (brimonidine tartrate ophthalmic solution 0.025%) is the first and only over-the-counter eye drop developed with low-dose brimonidine tartrate for the treatment of ocular redness due to minor eye irritations. In clinical studies including over 600 patients no tachyphylaxis and virtually no rebound redness was reported.

Yes

Not specified

Brimonidine tartrate

Topical

Over-the-counter

0.025%

This content is intended for health care professionals and providers only. The information contained on Beye.com, including text, graphics, images, and interactive activities, is for informational purposes only, and is not intended to be a substitute for professional medical advice. Beye LLC, via its Editors and Publisher, accepts no responsibility for any injury or damage to persons or property occasioned through the implementation of any ideas or use of any product described herein. Although great care is taken to ensure that all information is accurate, it is recommended that readers seek independent verification of advice on drugs and other product usage, surgical techniques and clinical processes prior to their use. References made in article may indicate usage of medical equipment or drugs at dosages, for periods of time, and in combination not included in the current prescribing information. Inclusion of advertising materials on the website thereof, does not constitute and representation or guarantee by Beye LLC of the quality of such products, or of the claims made.